Prostate Cancer Screening in Kuala Lumpur
PSA, PHI and risk assessment to help guide whether further prostate evaluation is needed.
Prostate cancer screening is not a diagnosis by itself. It helps assess individual risk, interpret PSA or PHI results, and decide whether monitoring, prostate MRI, or biopsy should be considered.
Overview
Prostate cancer is one of the most common cancers in men. In its early stages, it often causes no symptoms. For this reason, some men may benefit from discussing prostate cancer screening, especially if they are older or have additional risk factors.
Screening does not diagnose prostate cancer by itself. Instead, it helps identify men who may need closer assessment, further blood tests such as the Prostate Health Index (PHI), prostate MRI, or biopsy if clinically appropriate.
Assessment may include PSA interpretation, PHI review where appropriate, prostate MRI assessment, and discussion of whether further investigation is needed.
At A Glance
| Test / step | Purpose |
|---|---|
| PSA blood test | Helps identify men who may need further assessment |
| PHI blood test | May refine risk when PSA is raised or borderline |
| Prostate MRI | Looks for suspicious areas in the prostate |
| Biopsy | Confirms whether prostate cancer is present |
Who Should Consider Prostate Cancer Screening?
You may wish to discuss prostate cancer screening if you:
- Are aged 50 and above
- Have a father, brother, or close male relative with prostate cancer
- Have a strong family history of prostate, breast, or ovarian cancer
- Have had a previously raised PSA result
- Have a PSA level that is rising over time
- Have urinary symptoms and are concerned about prostate health
- Prefer to understand your personal prostate cancer risk before deciding on further tests
Some men at higher risk may be advised to consider screening earlier. The decision should be individualised after discussing the benefits, limitations, and possible next steps.
What Does Prostate Cancer Screening Involve?
Prostate cancer screening may include a combination of blood tests, clinical assessment, imaging, and further investigation when needed.
PSA Blood Test
PSA, or prostate-specific antigen, is a protein produced by the prostate.
A raised PSA level can be associated with prostate cancer, but it can also occur due to non-cancer causes such as benign prostate enlargement, inflammation, infection, recent ejaculation, catheterisation, or recent prostate procedures.
This is why PSA should not be interpreted on its own. The PSA level, PSA trend, age, prostate size, symptoms, and family history all need to be considered together.
Prostate Health Index / PHI
In some men with a raised or borderline PSA, a Prostate Health Index, or PHI, may be considered.
PHI is a blood test that combines different PSA measurements into a single score. It may help refine the risk of prostate cancer and support decision-making about whether further tests, such as prostate MRI or biopsy, are needed.
PHI does not diagnose prostate cancer by itself. It is interpreted together with the PSA level, PSA trend, age, prostate size, family history, examination findings, and MRI results where available.
A higher PHI score may suggest a higher likelihood of finding prostate cancer on biopsy, while a lower score may support a more cautious approach in selected cases.
Clinical Assessment
A urologist will usually review your age, symptoms, medical background, family history, medications, previous PSA results, and any previous prostate imaging or biopsy results.
In some cases, a prostate examination may be recommended as part of the overall assessment.
Prostate MRI
If the PSA, PHI, examination findings, or overall risk assessment raises concern, a multiparametric prostate MRI may be recommended.
MRI can help identify suspicious areas within the prostate. It may also help guide whether a biopsy is needed and which area should be sampled.
Prostate Biopsy
A prostate biopsy is considered when there is sufficient concern based on PSA, PHI, MRI findings, examination findings, or overall risk.
A biopsy involves taking small samples of prostate tissue for laboratory analysis. It is the test that confirms whether prostate cancer is present.
Not every raised PSA requires an immediate biopsy. In selected cases, repeat PSA testing, PHI testing, urine testing, treatment of infection, or MRI may be advised first.
A Raised PSA Does Not Always Mean Cancer
A high PSA result can be worrying, but it does not automatically mean prostate cancer.
PSA can be raised by several non-cancer causes, including:
- Benign prostate enlargement
- Prostate inflammation
- Urinary tract infection
- Recent ejaculation
- Recent catheterisation
- Recent prostate procedures
- Increasing age and prostate size
This is why further assessment is important. A urologist may look at the PSA pattern over time, PHI result, prostate size, MRI findings, symptoms, and personal risk factors before advising on the next step.
When Is Further Testing Needed?
Further assessment may be recommended if:
- PSA remains persistently raised
- PSA is rising over time
- PHI suggests a higher risk pattern
- MRI shows a suspicious prostate lesion
- There is an abnormal prostate examination
- There is a strong family history of prostate cancer
- Previous biopsy results were unclear but concern remains
The aim is not to perform every test on every man, but to choose the most appropriate next step based on individual risk.
Benefits and Limitations of Screening
Prostate cancer screening can help detect cancer earlier, when treatment may be more effective.
However, screening also has limitations. Some prostate cancers grow slowly and may never cause harm. Screening may sometimes detect cancers that do not need immediate treatment, leading to further tests, anxiety, or long-term monitoring.
A balanced discussion is important so that each man understands:
- What PSA and PHI can and cannot tell us
- Whether MRI or biopsy is needed
- The possibility of active surveillance for low-risk prostate cancer
- The risks and benefits of early diagnosis
- The most appropriate next step based on personal risk
Prostate Cancer Risk Assessment in Kuala Lumpur
A prostate cancer risk assessment may involve reviewing PSA results, PHI results where appropriate, urinary symptoms, family history, prostate size, MRI findings, and previous biopsy results if available.
The purpose of the assessment is to understand whether the findings are reassuring, whether monitoring is reasonable, or whether further investigation such as prostate MRI or biopsy should be considered.
At Prince Court Medical Centre, this assessment can be discussed with Dr Roger Anthony Idi, Consultant Urologist, as part of a structured review of prostate health and cancer risk.
When Should You See a Urologist?
You should consider seeing a urologist if you have:
- A raised or rising PSA
- A borderline PSA and are unsure what it means
- A high or concerning PHI result
- A family history of prostate cancer
- Blood in the urine or semen
- New or worsening urinary symptoms
- An abnormal prostate MRI
- Concerns about prostate cancer risk
Early assessment does not always mean treatment is needed. Sometimes, the most appropriate step is careful monitoring.
Considering Prostate Cancer Screening?
Prostate cancer screening is a personal decision. A consultation can help clarify what your PSA or PHI result may mean, whether your risk is low or concerning, and whether further tests such as prostate MRI or biopsy are appropriate.
Appointments with Dr Roger Anthony Idi are arranged through Prince Court Medical Centre.
FAQ
Does a high PSA always mean prostate cancer?
No. PSA can be raised by benign prostate enlargement, inflammation, infection, recent ejaculation, or recent prostate procedures. A raised PSA should be interpreted together with your age, symptoms, prostate size, PSA trend, family history, PHI result, and MRI findings where available.
What is PHI?
PHI stands for Prostate Health Index. It is a blood test that combines different PSA measurements into a single score. It may help estimate the likelihood of prostate cancer in men with a raised or borderline PSA.
Can PHI replace a prostate biopsy?
No. PHI does not diagnose prostate cancer. It helps refine risk and may support decision-making about whether MRI or biopsy is needed. A biopsy is still required to confirm prostate cancer.
Do all men need prostate cancer screening?
Not necessarily. Screening is usually considered based on age, risk factors, family history, PSA history, and personal preference. A discussion with a doctor can help decide whether screening is appropriate.
Can prostate cancer occur without symptoms?
Yes. Early prostate cancer often causes no symptoms. This is one reason why PSA testing may be discussed in men at a suitable age or higher risk.
If my PSA is high, do I need a biopsy?
Not always. Depending on the PSA level, PSA trend, PHI result, examination findings, and overall risk, your doctor may recommend repeating the PSA, arranging PHI testing, treating infection, performing prostate MRI, or considering biopsy.
What is the role of prostate MRI?
Prostate MRI helps identify suspicious areas within the prostate. It can support biopsy decisions and help target areas that may need sampling.
What happens if prostate cancer is found?
Treatment depends on the cancer grade, stage, PSA level, MRI findings, biopsy results, and overall health. Some low-risk cancers may be monitored with active surveillance, while others may need treatment such as surgery, radiotherapy, focal therapy, or hormonal therapy.